CEN/TC 206
| Registration number (WIID) | Project No. | Title | Status |
|---|---|---|---|
| 60725 | EN ISO 10993-18:2020 | Biological evaluation of medical devices - Part 18: Chemical characterization of medical device materials within a risk management process - Évaluation biologique (ISO/DIS 10993-18:2018) | Standarts spēkā |
| 65481 | EN ISO 22442-2:2020 | Medical devices utilizing animal tissues and their derivatives - Part 2: Controls on sourcing, collection and handling (ISO 22442-2:2020) | Standarts spēkā |
| 80820 | EN ISO 10993-5:2009/A11:2025 | Biological evaluation of medical devices - Part 5: Tests for in vitro cytotoxicity | Standarts spēkā |
| 22089 | EN ISO 10993-5:2009 | Biological evaluation of medical devices - Part 5: Tests for in vitro cytotoxicity (ISO 10993-5:2009) | Standarts spēkā |
| 67187 | EN ISO 10993-10:2023 | Biological evaluation of medical devices - Part 10: Tests for skin sensitization (ISO/DIS 10993-10:2020) | Standarts spēkā |
| 67095 | EN ISO 10993-12:2021 | Biological evaluation of medical devices - Part 12: Sample preparation and reference materials (ISO/DIS 10993-12:2019) | Standarts spēkā |
| 65727 | EN ISO 10993-4:2017 | Biological evaluation of medical devices - Part 4: Selection of tests for interactions with blood (ISO 10993-4:2017) | Standarts spēkā |
| 27051 | EN ISO 10993-13:2010 | Biological evaluation of medical devices - Part 13: Identification and quantification of degradation products from polymeric medical devices (ISO/DIS 10993-13:2008) | Standarts spēkā |
| 60724 | EN ISO 10993-16:2017 | Biological evaluation of medical devices - Part 16: Toxicokinetic study design for degradation products and leachables (ISO/DIS 10993-16:2016) | Standarts spēkā |
| 60722 | EN ISO 10993-9:2021 | Biological evaluation of medical devices - Part 9: Framework for identification and quantification of potential degradation products (ISO/DIS 10993-9:2018) | Standarts spēkā |
Displaying 21-30 of 198 results.